Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice

British Journal of Pharmacology

Volumn 174, Issue 20, 2017, Pages 3623-3639

  Caputi, Valentina ^a   Marsilio, Ilaria ^a   Filpa, Viviana ^b   Cerantola, Silvia ^a,c   Orso, Genny ^d   Bistoletti, Michela ^b   Paccagnella, Nicola ^a   De Martin, Sara ^a   Montopoli, Monica ^a   Dall'Acqua, Stefano ^a   Crema, Francesca ^e   Di Gangi, Iole Maria ^a   Galuppini, Francesca ^a   Lante, Isabella ^c   Bogialli, Sara ^a   Rugge, Massimo ^a   Debetto, Patrizia ^a   Giaroni, Cristina ^b   Giron, Maria Cecilia ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c SAN CAMILLO HOSPITAL   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; NEURONAL NITRIC OXIDE SYNTHASE; SUBSTANCE P; TOLL LIKE RECEPTOR 2; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID METABOLISM; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DEFECATION; DYSBIOSIS; GLIA; ILEUM CONTRACTION; IN VITRO STUDY; INTESTINAL DYSMOTILITY; INTESTINE FLORA; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; JUVENILE ANIMAL; MALE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; MYENTERIC PLEXUS; NERVE CELL NETWORK; NEUROMUSCULAR FUNCTION; NITRERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CECUM; CHEMICALLY INDUCED; DRUG EFFECT; GASTROINTESTINAL MOTILITY; ILEUM; INNERVATION; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE; STOMACH; SYNAPTIC TRANSMISSION;

ANIMALS; ANTI-BACTERIAL AGENTS; CECUM; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL MOTILITY; ILEUM; MALE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYENTERIC PLEXUS; STOMACH; SYNAPTIC TRANSMISSION;

EID: 85028523240     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13965     Document Type: Article

References (61)

1. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors. Br J Pharmacol 172: 5979–6023.
2. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
3. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
4. Anitha M, Vijay-Kumar M, Sitaraman SV, Gewirtz AT, Srinivasan S (2012). Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology 143: 1006–16.e4.
5. Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, Caputi V et al. (2014b). Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats. PLoS One 9 e116253.
6. Antonioli L, Fornai M, Awwad O, Giustarini G, Pellegrini C, Tuccori M et al. (2014a). Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats. Br J Pharmacol 171: 1314–1329.
7. Barbara G, Feinle-Bisset C, Ghoshal UC, Quigley EM, Santos J, Vanner S et al. (2016). The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology 150: 1305–1318.e8.
8. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R et al. (2005). Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 100: 2560–2568.
9. Bertrand PP, Polglaze KE, Chen H, Sandow SL, Walduck A, Jenkins TA et al. (2016). Excitability and synaptic transmission in the enteric nervous system: does diet play a role? Adv Exp Med Biol 891: 201–211.
10. Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF (2014). Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 20: 509–518.
11. Brun P, Giron MC, Qesari M, Porzionato A, Caputi V, Zoppellaro C et al. (2013). Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology 145: 1323–1333.
12. Brun P, Gobbo S, Caputi V, Spagnol L, Schirato G, Pasqualin M et al. (2015). Toll-like receptor-2 regulates production of glial-derived neurotrophic factors in murine intestinal smooth muscle cells. Mol Cell Neurosci 68: 24–35.
13. Caputi V, Marsilio I, Cerantola S, Roozfarakh M, Lante I, Galuppini F et al. (2017). Toll-like receptor 4 modulates small intestine neuromuscular function through nitrergic and purinergic pathways. Front Pharmacol 8: 350. https://doi.org/10.3389/fphar.2017.00350.
14. Ceran C, Karadas B, Kaya T, Arpacik M, Bagcivan I, Sarac B (2006). Do antibiotics contribute to postoperative ileus? Contractile responses of ileum smooth muscle in Guinea pigs to long-term parenteral ceftriaxone and ampicillin. ANZ J Surg 76: 1023–1026.
15. Coelho-Aguiar JM, Bon-Frauches AC, Gomes ALT, Veríssimo CP, Aguiar DP, Matias D et al. (2015). The enteric glia: identity and functions. Glia 63: 921–935.
16. Collins J, Borojevic R, Verdu EF, Huizinga JD, Ratcliffe EM (2014). Intestinal microbiota influence the early postnatal development of the enteric nervous system. Neurogastroenterol Motil 26: 98–107.
17. Crawford JD, Chandley MJ, Szebeni K, Szebeni A, Waters B, Ordway GA (2015). Elevated GFAP protein in anterior cingulate cortical white matter in males with autism spectrum disorder. Autism Res 8: 649–657.
18. Currò D, De Marco T, Preziosi P (2002). Involvement of peptide histidine isoleucine in non-adrenergic non-cholinergic relaxation of the rat gastric fundus induced by high-frequency neuronal firing. Naunyn Schmiedebergs Arch Pharmacol 366: 578–586.
19. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SPA, Giembycz MA et al. (2015). Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 172: 3461–3471.
20. Dall'Olmo L, Fassan M, Dassie E, Scarpa M, Realdon S, Cavallin F et al. (2014). Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. PLoS One 9 e112862.
21. Filpa V, Carpanese E, Marchet S, Pirrone C, Conti A, Rainero A et al. (2017). Nitric oxide regulates homeoprotein OTX1 and OTX2 expression in the rat myenteric plexus after intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 312: G374–G389.
22. Foster JA, McVey Neufeld K-A (2013). Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36: 305–312.
23. Fröhlich EE, Farzi A, Mayerhofer R, Reichmann F, Jačan A, Wagner B et al. (2016). Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun 56: 140–155.
24. Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R (2015). How the intricate interaction among Toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology. J Immunol Res 2015: 489821.
25. Furness JB (2012). The enteric nervous system and neurogastroenterology. Nat Rev Gastroenterol Hepatol 9: 286–294.
26. Ge X, Ding C, Zhao W, Xu L, Tian H, Gong J et al. (2017). Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J Transl Med 15: 13.
27. Giron MC, Bin A, Brun P, Etteri S, Bolego C, Florio C et al. (2008). Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway. Gastroenterology 134: 1116–1126.
28. Grasa L, Abecia L, Forcén R, Castro M, de Jalón JA, Latorre E et al. (2015). Antibiotic-induced depletion of murine microbiota induces mild inflammation and changes in toll-like receptor patterns and intestinal motility. Microb Ecol 70: 835–848.
29. Josefsdottir KS, Baldridge MT, Kadmon CS, King KY (2017). Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota. Blood 129: 729–739.
30. Hansen TH, Gøbel RJ, Hansen T, Pedersen O (2015). The gut microbiome in cardio-metabolic health. Genome Med 7: 33.
31. Hyland NP, Cryan JF (2016). Microbe-host interactions: influence of the gut microbiota on the enteric nervous system. Dev Biol 417: 182–187.
32. Kabouridis PS, Lasrado R, McCallum S, Chng SH, Snippert HJ, Clevers H et al. (2015). The gut microbiota keeps enteric glial cells on the move; prospective roles of the gut epithelium and immune system. Gut Microbes 6: 398–403.
33. Kabouridis PS, Pachnis V (2015). Emerging roles of gut microbiota and the immune system in the development of the enteric nervous system. J Clin Invest 125: 956–964.
34. Kennedy PJ, Cryan JF, Dinan TG, Clarke G (2014). Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol 20: 14105–14125.
35. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577–1579.
36. Kuribayashi H, Miyata M, Yamakawa H, Yoshinari K, Yamazoe Y (2012). Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling. Eur J Pharmacol 697: 132–138.
37. Lecci A, Capriati A, Altamura M, Maggi CA (2006). Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human. Auton Neurosci 126–127: 232–249.
38. Li ZS, Schmauss C, Cuenca A, Ratcliffe E, Gershon MD (2006). Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J Neurosci 26: 2798–2807.
39. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K (2014). Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34: 15490–15496.
40. McGrath JC, Lilley E (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189–3193.
41. McQuade RM, Carbone SE, Stojanovska V, Rahman A, Gwynne RM, Robinson AM et al. (2016). Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice. Br J Pharmacol 173: 3502–3521.
42. Messenger JP, Furness JB (1990). Projections of chemically-specified neurons in the guinea-pig colon. Arch Histol Cytol 53: 467–495.
43. Milleit B, Smesny S, Rothermundt M, Preul C, Schroeter ML, von Eiff C et al. (2016). Serum S100B protein is specifically related to white matter changes in schizophrenia. Front Cell Neurosci 10: 33.
44. Okun E, Griffioen KJ, Lathia JD, Tang S-C, Mattson MP, Arumugam TV (2009). Toll-like receptors in neurodegeneration. Brain Res Rev 59: 278–292.
45. Quigley EMM (2011). Microflora modulation of motility. J Neurogastroenterol Motil 17: 140–147.
46. Reikvam DH, Erofeev A, Sandvik A, Grcic V, Jahnsen FL, Gaustad P et al. (2011). Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One 6 e17996.
47. Robinson AM, Stojanovska V, Rahman AA, McQuade RM, Senior PV, Nurgali K (2016). Effects of oxaliplatin treatment on the enteric glial cells and neurons in the mouse ileum. J Histochem Cytochem 64: 530–545.
48. Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall H-U, Bamberg K et al. (2013). Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17: 225–235.
49. Smith TK, Robertson WJ (1998). Synchronous movements of the longitudinal and circular muscle during peristalsis in the isolated guinea-pig distal colon. J Physiol 506: 563–577.
50. Sommer F, Bäckhed F (2013). The gut microbiota--masters of host development and physiology. Nat Rev Microbiol 11: 227–238.
51. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH et al. (2016). The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
52. Stenkamp-Strahm CM, Kappmeyer AJ, Schmalz JT, Gericke M, Balemba O (2013). High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes. Cell Tissue Res 354: 381–394.
53. Tancowny BP, Karpov V, Schleimer RP, Kulka M (2010). Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2. Immunology 131: 220–230.
54. Theriot CM, Bowman AA, Young VB (2016). Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere 1 e00045-15.
55. Turco F, Sarnelli G, Cirillo C, Palumbo I, De Giorgi F, D'Alessandro A et al. (2014). Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells. Gut 63: 105–115.
56. Ubeda C, Pamer EG (2012). Antibiotics, microbiota, and immune defense. Trends Immunol 33: 459–466.
57. Ungaro R, Bernstein CN, Gearry R, Hviid A, Kolho K-L, Kronman MP et al. (2014). Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol 109: 1728–1738.
58. Verdú EF, Bercik P, Verma-Gandhu M, Huang X-X, Blennerhassett P, Jackson W et al. (2006). Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55: 182–190.
59. Zizzo MG, Mule F, Serio R (2003). Duodenal contractile activity in dystrophic (mdx) mice: reduction of nitric oxide influence. Neurogastroenterol Motil 15: 559–565.
60. Zizzo MG, Mulè F, Serio R (2004). Interplay between PACAP and NO in mouse ileum. Neuropharmacology 46: 449–455.
61. Zoppellaro C, Bin A, Brun P, Banzato S, Macchi V, Castagliuolo I et al. (2013). Adenosine-mediated enteric neuromuscular function is affected during herpes simplex virus type 1 infection of rat enteric nervous system. PLoS One 8 e72648.